Table 1.
Baseline characteristics. This table demonstrates the baseline characteristics of the study cohort.
| Baseline Characteristics | ||||
|---|---|---|---|---|
| Overall | Three-Cusp View | Cusp-Overlap View | p-Value | |
| n | 122 | 61 | 61 | |
| Age (years) | 83.2 [79.8, 87.4] | 83.3 [80.4, 87.9] | 82.5 [79.0, 86.8] | 0.15 |
| Sex (female) | 25 (20.5) | 10 (16.4) | 15 (24.6) | 0.37 |
| BMI | 25.2 [22.8, 28.3] | 25.0 [21.8, 27.4] | 25.5 [23.3, 28.7] | 0.11 |
| STS Score | 3.3 [2.2, 4.6] | 3.1 [2.0, 4.9] | 3.5 [2.6, 3.7] | 0.94 |
| NYHA functional class | 0.92 | |||
| NYHA II | 14 (14.4) | 7 (14.0) | 7 (14.9) | |
| NYHA III | 78 (80.4) | 40 (80.0) | 38 (80.9) | |
| NYHA IV | 5 (5.2) | 3 ( 6.0) | 2 (4.3) | |
| AV dpmean (mmHg) | 44.5 (16.8) | 47.2 (17.4) | 41.7 (15.9) | 0.09 |
| AV dpmax (mmHg) | 69.6 (26.3) | 74.1 (27.4) | 65.0 (24.6) | 0.07 |
| AV opening area (cm2) | 0.66 (0.21) | 0.64 (0.22) | 0.67 (0.19) | 0.45 |
| LVEF (%) | 59.4 [55.0, 60.0] | 58.0 [52.0, 60.0] | 60.0 [56.5, 60.0] | 0.01 |
| TAPSE (mm) | 22.18 (7.30) | 22.37 (8.84) | 21.98 (5.10) | 0.80 |
| Diabetes | 20 (20.2) | 10 (19.6) | 10 (20.8) | >0.99 |
| Coronary artery disease | 50 (49.5) | 22 (42.3) | 28 (57.1) | 0.20 |
| Previous MI | 5 (5.4) | 1 (2.1) | 4 (8.7) | 0.35 |
| Previous PCI | 22 (22.0) | 8 (15.7) | 14 (28.6) | 0.19 |
| Previous CABG | 8 (7.1) | 4 (6.5) | 4 (6.5) | >0.99 |
| Atrial fibrillation | 51 (44.7) | 25 (41.7) | 26 (48.1) | 0.61 |
| Prior cardiac surgery | 10 (8.9) | 5 (8.8) | 5 (8.8) | 0.73 |
Qualitative data are presented as n (%); Quantitative data are presented as median [IQR] or mean (SD); BMI, body mass index; STS, Society of Thoracic Surgeons; AV, aortic valve; dpmean, mean pressure gradient; dpmax, maximum pressure gradient; NYHA, New York Heart Association; LVEF, left ventricular ejection fraction; TAPSE, tricuspid annular plane systolic excursion; MI; myocardial infarction; PCI, percutaneous coronary intervention; CABG, coronary artery bypass graft.